2.99 USD
↗ 0.12 (4.29%)PRE MARKET (AS OF 04:15 AM EST)
Lexeo Therapeutics, Inc. Common Stock (LXEO) trades at $2.99 per share. Our models show a "Sell" technical signal alongside a "Neutral" fundamental rating. This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation metrics suggest LXEO is trading at a discount to its peers, earning an "Attractively Valued" rating.
Technical & fundamental data as of Nov 13, 2026.